|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-30
|
$1,889,710
|
$37,794
|
EDELSON, RICHARD
|
YALE UNIVERSITY
|
|
Washington University Small Animal Imaging Resource
|
5U24CA083060-10
|
$633,099
|
$633,099
|
ACKERMAN, JOSEPH
|
WASHINGTON UNIVERSITY
|
|
Virtual Bone Biopsy: Transfer to the clinical arena
|
5R44CA110227-05
|
$892,150
|
$892,150
|
KLEEREKOPER, Michael
|
MICROMRI, INC.
|
|
Virotherapy for Relapsed Refractory Multiple Myeloma
|
5R01CA125614-03
|
|
$0
|
DISPENZIERI, ANGELA
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Vanderbilt In Vivo Cellular and Molecular Imaging Center
|
1P50CA128323-01A1
|
$1,500,000
|
$165,000
|
GORE, JOHN
|
VANDERBILT UNIVERSITY
|
|
Vaccination With Peptide-loaded alphaDC1s For Malignant Gliomas
|
5R21CA117152-02
|
$282,150
|
$14,108
|
OKADA, HIDEHO
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-35S1
|
$59,955
|
$1,799
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-35
|
$4,795,480
|
$143,864
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UT Southwestern Small Animal Imaging Resource
|
5U24CA126608-02
|
$451,375
|
$112,844
|
MASON, RALPH
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-20
|
$1,758,769
|
$17,588
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
USING VIRAL NANOPARTICLES TO TARGET CANCER
|
5R01CA112075-04
|
$746,719
|
$186,680
|
MANCHESTER, MARIANNE
|
SCRIPPS RESEARCH INSTITUTE
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
2U54CA096297-06A1
|
$1,584,860
|
$126,789
|
FRONTERA-ROURA, WALTER
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
2U54CA096300-06A1
|
$1,216,467
|
$231,129
|
DUBOIS, RAYMOND
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S1
|
$80,987
|
$3,239
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-24
|
$1,553,887
|
$62,155
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-04S1
|
$60,563
|
$4,845
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-04
|
$1,332,378
|
$106,590
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-21S1
|
$61,058
|
$4,274
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-21
|
$5,994,681
|
$419,628
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
1P30CA134274-01
|
$1,463,613
|
$29,272
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S4
|
$2,630,152
|
$341,920
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S5
|
$61,584
|
$8,006
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Ultra-Sensitive MR Probes for Molecular Diagnosis of Lung Cancer
|
1R01CA129011-01A1
|
$325,775
|
$325,775
|
GAO, JINMING
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
Ultra-fast 15N Imaging in Choline in Cancer
|
5R01CA122513-02
|
$258,039
|
$258,039
|
ROSS, BRIAN
|
HUNTINGTON MEDICAL RESEARCH INSTITUTES
|
|
U.W. Radiological Sciences Training Program
|
5T32CA009206-30
|
$439,995
|
$109,999
|
DeLuca, Paul
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Two Compartment Models to Improve Brain Tumor Therapy
|
9R01CA137488-14A1
|
$494,277
|
$172,997
|
NEUWELT, EDWARD
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
|
Tumor Hypoxia Imaging - Laboratory and Clinical Studies
|
5P01CA115675-03
|
$1,863,192
|
$931,596
|
LING, CLIFTON
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Tumor and PTK-Targeted Therapy by FUS1 and PTK inhibitor
|
5R01CA116322-02
|
$292,600
|
$73,150
|
JI, LIN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
True 3D Display for IGRI
|
1R43CA138566-01
|
$150,000
|
$37,500
|
Geng, Jason
|
XIGEN, LLC
|
|
Treatment Planning using Physiologic MRI Data
|
3R01CA118365-02S1
|
$21,119
|
$21,119
|
MEYERAND, M
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Treatment Planning using Physiologic MRI Data
|
5R01CA118365-02
|
$268,227
|
$268,227
|
MEYERAND, M
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Transcatheter Intra-arterial Perfusion MRI Monitoring of Liver Tumor Embolization
|
1R01CA134719-01
|
$302,637
|
$302,637
|
LARSON, ANDREW
|
NORTHWESTERN UNIVERSITY
|
|
Training Program in Translational Radiation Oncology
|
5T32CA113267-04
|
$307,688
|
$76,922
|
ROBBINS, MICHAEL
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Training in Translational Tobacco Science
|
1K05CA139871-01
|
$170,073
|
$17,007
|
Baker, Timothy
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Training in Radiation Oncology
|
5T32CA061801-13
|
$186,145
|
$37,229
|
LING, CLIFTON
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Time Domian Electron Paramagnetic Resonance Imaging
|
Z01 BC 010476
|
$462,573
|
$462,574
|
Cherukuri, Murali
|
CCR (NCI)
|
|
Thioredoxin Inhibitor, PX-12, in Phase II Clinical Trial
|
5R44CA075923-08
|
$973,839
|
$486,920
|
KIRKPATRICK, LYNN
|
PROLX PHARMACEUTICALS CORPORATION
|
|
The Siteman Center of Cancer Nanotechnology Excellence *
|
5U54CA119342-04
|
$3,284,302
|
$492,645
|
WICKLINE, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
The Role of Selenium in Intestinal Inflammation and Cancer
|
5R21CA123334-02
|
$199,200
|
$99,600
|
Jelicks, Linda
|
YESHIVA UNIVERSITY
|
|
The Role of Inflammation and Stroma in Digestive Cancer
|
3U54CA126513-02S1
|
$29,953
|
$14,977
|
Wang, Timothy
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The Role of Inflammation and Stroma in Digestive Cancer
|
3U54CA126513-03S1
|
$59,906
|
$29,953
|
Wang, Timothy
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The Role of Inflammation and Stroma in Digestive Cancer
|
5U54CA126513-03
|
$854,654
|
$427,327
|
Wang, Timothy
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-15S1
|
$91,948
|
$3,678
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-15S2
|
$49,383
|
$1,975
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-15S3
|
$83,152
|
$3,326
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-15
|
$5,084,061
|
$203,362
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-33S1
|
$89,606
|
$896
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
5P30CA016058-33
|
$3,753,703
|
$37,537
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The MIT-Harvard Center of Cancer Nanotechnology Excelle*
|
5U54CA119349-04
|
$4,010,088
|
$2,005,044
|
LANGER, ROBERT
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
The Annual Blood-Brain Barrier Consortium Meeting
|
5R13CA086959-09
|
$9,710
|
$2,913
|
NEUWELT, EDWARD
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
Total relevant funding to Nuclear Magnetic Resonance Imaging (NMR) for this search: $84,992,252
|